title: Control of high hematocrit levels in a hemodialysis patient with an angiotensin-converting enzyme inhibitor.
authors.forename: M
authors.initials: M
authors.lastname: Yabana
authors.forename: M
authors.initials: M
authors.lastname: Kihara
authors.forename: Y
authors.initials: Y
authors.lastname: Toya
authors.forename: K
authors.initials: K
authors.lastname: Tamura
authors.forename: N
authors.initials: N
authors.lastname: Takagi
authors.forename: K
authors.initials: K
authors.lastname: Kurita
authors.forename: M
authors.initials: M
authors.lastname: Onishi
authors.forename: S
authors.initials: S
authors.lastname: Umemura
mesh_terms: D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000097:blood / Q000628:therapy; D006400:Hematocrit; D006801:Humans; D008297:Male; D011086:Polycythemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006435:Renal Dialysis / Q000009:adverse effects*; D013841:Thiazepines / Q000627:therapeutic use*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D013841:Thiazepines; C055603:temocapril hydrochloride